The high-performance technology CRISPR/Cas9 improves knowledge and management of acute myeloid leukemia
Knowledge on acute myeloid leukemia pathogenesis and treatment has progressed recently, but not enough to provide ideal management. Improving the prognosis of acute myeloid leukemia patients depends on advances in molecular biology for the detection of new therapeutic targets and the production of e...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Palacký University Olomouc, Faculty of Medicine and Dentistry
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/80b275a3ae6e4e0da9613e401454cc5f |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|